Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Linamarin is a cyanogenic glucoside primarily found in the roots and leaves of plants such as cassava, lima beans, and flax [1]. It functions as a chemical defense mechanism in plants; upon tissue damage, it is hydrolyzed by the enzyme linamarase to release toxic hydrogen cyanide (HCN) [2]. In therapeutic research, linamarin has been explored as a prodrug in Gene-Directed Enzyme Prodrug Therapy (GDEPT), where the linamarase gene is delivered to cancer cells to facilitate localized cyanide production and subsequent cell death [3]. However, linamarin is more widely recognized for its role in human pathology due to dietary exposure from poorly processed cassava, which can lead to acute cyanide poisoning or chronic neurological conditions such as Konzo [4]. Its mechanism of action involves the inhibition of cytochrome c oxidase by the released cyanide, which halts mitochondrial respiration [5]. This dual nature as both a potential therapeutic agent and a significant environmental toxin makes it a molecule of interest in both oncology and toxicology.
Linamarin acts as a prodrug that is hydrolyzed by the enzyme linamarase to release hydrogen cyanide (HCN). HCN inhibits cytochrome c oxidase in the mitochondrial electron transport chain, preventing cellular respiration and leading to cytotoxic effects [2, 5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Linamarin.